广东众生药业股份有限公司关于公司股票交易异常波动的公告

Group 1 - The company's stock (Zhongsheng Pharmaceutical, stock code: 002317) experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from November 12 to November 14, 2025 [2] - The company's board of directors conducted a verification and found no need for corrections or supplements to previously disclosed information, and no significant undisclosed information affecting stock prices was identified [2][3] - The company's current operational situation is normal, with no significant changes in the internal or external business environment [2] Group 2 - The board confirmed that there are no undisclosed matters that should be disclosed according to the Shenzhen Stock Exchange listing rules, nor any related planning or negotiations that could significantly impact the stock price [3] - The company has not violated any information disclosure regulations and will continue to fulfill its disclosure obligations in accordance with relevant laws and regulations [5]